GlassScriptPhysician profile
Michael David Lutz
NPI 1326020157
$19,793.51
in general payments reported to CMS, 2019-2025
36 companies · $33.34 in 2025
The $33.34 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,361 · 2020: $7,495 · 2021: $1,418 · 2022: $4,078 · 2023: $970 · 2024: $438 · 2025: $33.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,441.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,441.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $11,650.03 | 2019-2024 | Adstiladrin |
| Tolmar Pharmaceuticals, INC. | $3,700.74 | 2019-2022 | |
| Janssen Biotech, INC. | $1,194.76 | 2019-2023 | Erleada |
| Astellas Pharma US INC | $581.27 | 2019-2024 | Myrbetriq, Xtandi |
| Dendreon Pharmaceuticals LLC | $330.26 | 2019-2024 | Provenge |
| Pfizer INC. | $279.67 | 2019-2024 | |
| Teleflex LLC | $184.54 | 2022-2023 | Urolift |
| Myriad Genetic Laboratories, INC. | $169.26 | 2022-2023 | Prolaris |
| Sun Pharmaceutical Industries INC. | $160.73 | 2019-2023 | Yonsa |
| Bayer Healthcare Pharmaceuticals INC. | $146.59 | 2019-2023 | |
| Blue Earth Diagnostics | $129.77 | 2019-2021 | |
| Medtronic, INC. | $113.75 | 2022-2024 | Interstim |
| Endo Pharmaceuticals INC. | $112.49 | 2019-2022 | |
| Laborie Medical Technologies Corp. | $105.53 | 2023-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Merck Sharp & Dohme LLC | $99.62 | 2019-2024 | Keytruda, Lynparza, Welireg |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $93.67 | 2019-2023 | Xyosted, Tlando, Nocdurna |
| Boston Scientific Corporation | $92.27 | 2019-2025 | Rezum Generator, Ams 700 |
| Urogen Pharma, INC. | $67.30 | 2022-2024 | Jelmyto |
| Abbvie INC. | $52.20 | 2022-2024 | |
| Coloplast Corp | $51.37 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $47.87 | 2023-2024 | Lynparza, Evusheld |
| Clarus Therapeutics INC. | $44.57 | 2021 | |
| Photocure INC | $44.29 | 2023 | Cysview |
| Halozyme INC | $42.18 | 2023 | |
| Progenics Pharmaceuticals, INC. | $41.23 | 2022 | |
| Sumitomo Pharma America, INC. | $40.18 | 2023-2024 | Orgovyx, Gemtesa |
| Janssen Scientific Affairs, LLC | $32.92 | 2019 | |
| Procept Biorobotics Corporation | $26.24 | 2022 | |
| Genzyme Corporation | $25.59 | 2023 | |
| Immunitybio, INC. | $24.49 | 2024 | |
| 180 Medical, INC. | $24.15 | 2019 | |
| Zyla Life Sciences, INC. | $19.16 | 2019 | |
| Amgen INC. | $18.72 | 2019 | |
| Allergan, INC. | $16.04 | 2021 | |
| Travere Therapeutics, INC. | $15.25 | 2019 | |
| Axonics, INC. | $14.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lutz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.